Radiation Therapy for Cutaneous T-Cell Lymphomas

Slides:



Advertisements
Similar presentations
Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.
Advertisements

Auris O. Huen, PharmD, MD, Ellen J. Kim, MD  Dermatologic Clinics 
Laser treatment of medical skin disease in women
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Clinical application of lying-on-the-floor total skin electron irradiation for frail patients with cutaneous lymphoma: An emphasis on the importance of.
Volume 16, Issue 1, Pages (January 2017)
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
Stefano Caccavale, MD, Eleonora Ruocco, MD, PhD  Clinics in Dermatology 
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 
Kavitha K. Reddy, MD, Jeremy A. Brauer, MD, Roy G. Geronemus, MD 
Kayser-Fleischer Rings in a Patient With Basal Cell Carcinoma: Fortuitous Diagnosis of Presymptomatic Wilson's Disease  DAVID G. BRODLAND, M.D.  Mayo.
Volume 3, Issue 6, Pages (November 2017)
Evaluation of Proteinuria
Targeted therapy in melanoma
William L. Lanier, MD  Mayo Clinic Proceedings 
Practical Management of CD30+ Lymphoproliferative Disorders
Baldness reversed by chemotherapy
Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B- cell lymphomas: A retrospective study  Amrita Goyal, MD, Joi B.
Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging  Amish P. Shah, PhD, Tomas Dvorak,
Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,
Radiosurgical Management of Brain Metastases
Michele A. Hanson, M.D., Daniel A. Dumesic, M.D. 
Clinical and Translational Radiation Oncology
Auris O. Huen, PharmD, MD, Ellen J. Kim, MD  Dermatologic Clinics 
Brenda G. Clark, PhD, Robert J
Pain in cancer survivors; filling in the gaps
Extracorporeal Photopheresis and Adjuvant Aerosolized Granulocyte-Macrophage Colony-Stimulating Factor for Sézary Syndrome  Saskia A. Bouwhuis, MD, Svetomir.
Pulmonary Infiltrates and Eosinophilia Associated With Sulfasalazine
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
M. J. Röβler, G. Rappl, M. Muche, D. O. Hasselmann, W. Sterry, W
Physics and Imaging in Radiation Oncology
Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma
The applicability and prognostic value of the TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome.
Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments  Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.
Treatment of psoriasis vulgaris using low-dose naltrexone
Paul M. Graham, DO, Allison Melkonian, BS, David Fivenson, MD 
Mosquito-Borne Hemorrhagic Fevers
Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet.
Chagas Disease: Coming to a Place Near You
Cutaneous metastatic disease: Burkitt lymphoma
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Nicole Leung, BS, Adela R. Cardones, MD, Nicole Larrier, MD 
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Volume 1, Issue 2, Pages (March 2015)
Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC 
Volume 4, Issue 6, Pages (July 2018)
Treatment of Carcinoma of the Esophagus or Cardia*
On the conversion of dose to bone to dose to water in radiotherapy treatment planning systems  Nick Reynaert, Frederik Crop, Edmond Sterpin, Iwan Kawrakow,
Charles Hilton Fagge ( ): an early skin physician in London
Volume 5, Issue 1, Pages (January 2019)
A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability  Daniel J. Lewis, BA, Madeleine.
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?  Georgios Ntentas, DPhil, Katerina Dedeckova, MD, Michal.
Atopic Dermatitis: A Heterogeneous Disorder
Iris Metastasis from Small-Cell Lung Cancer
Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)
Assessing Genetic Expression Profiles in Melanoma Diagnosis
Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability  Prashant Gabani, MD, Benjamin W.
Olga Vornicova, MD, Gil Bar-Sela, MD  JAAD Case Reports 
Preface Dermatologic Clinics
Lymphoma Associated With Human Immunodeficiency Virus Infection
New Treatments Have Changed the Game
Volume 5, Issue 4, Pages (April 2019)
Guy S. Reeder, M.D.  Mayo Clinic Proceedings 
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma  Julianna K. Bronk, Nandita Guha-Thakurta,
Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor  Audrey A. Jacobsen, BA, John Strasswimmer,
Tofacitinib therapy for children with severe alopecia areata
Peripheral Tissue Examination for Malignant Lesions of the Skin
Presentation transcript:

Radiation Therapy for Cutaneous T-Cell Lymphomas Daniel J. Tandberg, MD, Oana Craciunescu, PhD, Chris R. Kelsey, MD  Dermatologic Clinics  Volume 33, Issue 4, Pages 703-713 (October 2015) DOI: 10.1016/j.det.2015.05.006 Copyright © 2015 The Authors Terms and Conditions

Fig. 1 Medical linear accelerator used to generate and deliver external beam radiation therapy. Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions

Fig. 2 Plot of percentage of radiation dose (%) versus depth (mm) for various electron beam energies from 6 to 22 MeV. Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions

Fig. 3 Method of local electron beam radiation therapy to cutaneous lymphoma lesions. A margin is drawn around visible or palpable disease (A). A lead cutout is created conforming to the target volume (B). The patient is positioned on the treatment table and the electron beam therapy is delivered by a medical linear accelerator (C). Note the bolus material placed over the cutaneous lesion that ensures the maximum dose is delivered to the skin surface (arrow). Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions

Fig. 4 The six treatment positions used for total skin electron beam therapy. (From Smith BD, Wilson LD. Management of mycosis fungoides. Part 2: treatment. Oncology 2003;17(10):1424; with permission.) Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions

Fig. 5 Patient undergoing total skin electron beam therapy. Both internal eye and mouth shields are used. The hands and feet are shielded and treated separately with photon fields. Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions

Fig. 6 Localized primary cutaneous anaplastic large cell lymphoma at diagnosis (A) and 3 months after radiation therapy (B). Dermatologic Clinics 2015 33, 703-713DOI: (10.1016/j.det.2015.05.006) Copyright © 2015 The Authors Terms and Conditions